Omidenepag manufacturers
- Omidenepag
-
- $42.00
-
2026-07-27
- CAS:1187451-41-7
- Purity: 99.77%
- Supply Ability: 10g
|
| | Omidenepag Basic information |
| Product Name: | Omidenepag | | Synonyms: | Omidenepag;Glycine, N-[6-[[[[4-(1H-pyrazol-1-yl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl]-2-pyridinyl]-;Omidenepag (free acid);(6-((N-(4-(1H-Pyrazol-1-yl)benzyl)pyridine-3-sulfonamido)methyl)pyridin-2-yl)glycine | | CAS: | 1187451-41-7 | | MF: | C23H22N6O4S | | MW: | 478.52 | | EINECS: | | | Product Categories: | | | Mol File: | 1187451-41-7.mol |  |
| | Omidenepag Chemical Properties |
| Boiling point | 769.4±70.0 °C(Predicted) | | density | 1.39±0.1 g/cm3(Predicted) | | solubility | Acetonitrile: Slightly soluble: 0.1-1 mg/ml
DMSO: Sparingly soluble: 1-10 mg/ml | | pka | 3.38±0.10(Predicted) | | form | Solid | | color | White to off-white |
| | Omidenepag Usage And Synthesis |
| Uses | Omidenepag, is a novel selective, non-prostanoid EP2 receptor agonist for the treatment of Glaucoma: | | IC 50 | hEP4: 5480 nM (IC50); hEP2: 10 nM (IC50); hEP2: 1.1 nM (EC50) | | References | [1] RYO IWAMURA*. Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl[J]. Journal of Medicinal Chemistry, 2018, 61 15: 6869-6891. DOI: 10.1021/acs.jmedchem.8b00808 |
| | Omidenepag Preparation Products And Raw materials |
|